发展和验证一个预后诺莫格拉姆的后传导管大动脉替换心力衰竭在同时症状大动脉狭窄和心力衰竭的患者住院治疗与保存的喷射小部分:一个多中心研究
Jun Wang1,2,3,4, Shoupeng Duan5, Hui Li1
1Department of Cardiology The First Affiliated Hospital of Bengbu Medical University Bengbu Anhui China.
Journal of the American Heart Association
|March 10, 2026
概括
一个新的诺米图准确地预测了TAVR后患有严重大动脉狭窄和保留射出分数的患者的心力衰竭住院的情况. 这种工具有助于临床医生管理高风险患者,改善治疗结果.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 生物统计学 生物统计学
背景情况:
- 目前的风险分层模型不足以识别心力衰竭 (HF) 住院的高风险患者.
- 这种限制在症状性大动脉狭窄和具有保留射出分数 (HFpEF) 的HF患者中尤其明显.
- 现有的模型未能有效地分层这种特定的高风险人群的风险,经过过导管大动脉置换 (TAVR).
研究的目的:
- 开发和验证HF住院治疗的新型预测模型.
- 确定重症大动脉狭窄症患者和TAVR后的HFpEF中HF住院治疗的关键预测因素.
- 创建一个临床决策支持工具,以改善风险评估和患者管理.
主要方法:
- 一项多中心队列研究包括321名患有严重大动脉狭窄和HFpEF的患者接受TAVR.
- 使用了机器学习技术 (随机森林,XGBoost,Cox回归) 和特征选择算法 (Boruta,LASSO).
- 开发了基于考克斯回归的名图,并进行了外部验证,与现有风险评分进行性能比较.
主要成果:
- 基于考克斯回归的诺图表在外部验证中显示出优异的预测性能 (AUC为12个月0.824,20个月0.818).
- 诺米图识别了6个独立的预测因素,并显示出出色的校准和临床实用性.
- 它在歧视和重新分类方面表现优于欧洲心脏操作风险评估系统 (EuroSCORE).
结论:
- 一个由机器学习衍生出来的,包含新陈代谢生物标志物的名录图准确地预测高风险患者的高风险肺炎住院治疗.
- 该工具为症状性大动脉狭窄和TAVR后的HFpEF患者提供了改进的风险分层.
- 一个互动的基于网络的工具,以促进临床决策的点的护理实施.
更多相关视频
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.9K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.9K
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
510
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
510
01:27Mitral Stenosis IV: Nursing Management
337
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
337
01:17Pathophysiology of Heart Failure
4.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
01:29Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
01:25Aortic Regurgitation III: Medical Management
529
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
529
01:30Heart Failure V: Medical Management
453
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
453